Center for Clinical Epidemiology and Biostatistics

Improving Population Health Through Research and Training

Home

--

Announcements

Training Researchers to Focus on Patient-Centered Care

Stephen Kimmel, MD, MSCE, is co-Principal Investigator of the new Transforming the Generation and Adoption of PCOR into Practice (T-GAPP) project, which received a $3 million award from the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Outcomes Research Institute (PCORI). Read more.

Junko Takeshita Wins Young Investigator Award

The American Academy of Dermatology has selected Junko Takeshita, MD, PhD, MSCE, for a 2018 Young Investigator Award. Dr. Takeshita spoke on camera about disparities in care—such as racial disparities in treatment for severe psoriasis—at the AAD’s annual meeting. View her remarks.

AGA Honors David Goldberg and James Lewis

The American Gastroenterological Association has honored David Goldberg, MD, MSCE (pictured) with its Young Investigator Award and James Lewis, MD, MSCE, with its Distinguished Educator Award. The awards acknowledge outstanding contributions and achievements in gastroenterology. Read more.

View More

In the News

Kickoff Rule Change Tied to Fewer Concussions

October 2018

A rule change significantly reduces concussions from kickoffs, an especially dangerous play, in college football, reported Douglas Wiebe, PhD, and colleagues recently in the Journal of the American Medical Association. The positive results in the Ivy League athletic conference show how a public-health intervention can emerge from collaboration among injury epidemiologists, coaches and athletic trainers, commented Dr. Wiebe.

Read the CNN coverage.

More Results from Innovative Trial Point Toward Greater Transplant Kidney Supply

August 2018

In a continuation of their trailblazing work, Peter Reese, MD, MSCE, and David Goldberg, MD, MSCE, report more encouraging results for patients who need transplants. A total of 20 have now successfully received hepatitis C positive kidneys plus antiviral therapy.

Read the article by the Associated Press.

Hepatitis C Patients Often Denied Live-Saving Drugs

June 2018

New research led by Vincent Lo Re III, MD, MSCE, shows that people with hepatitis C still frequently meet with insurance denials for once-a-day pills that became available in the United States in 2014 and have a 95 percent cure rate, with few side effects. Read more.

Read the article in The Philadelphia Inquirer.
View More

About the CCEB

How can we answer and anticipate the pressing health issues we face together as a society? At the CCEB we rise to that challenge through research and training in epidemiology and in biostatistics. We solve problems facing patients and populations. MORE

CONTACT

  

Follow Us